| Attribute |
Value |
| 52 Week Change |
-0.8291765 |
| Address1 |
Hohstrasse 1 |
| All Time High |
2,940.0 |
| All Time Low |
1.83 |
| Ask |
3.94 |
| Ask Size |
1 |
| Average Daily Volume10 Day |
3,660 |
| Average Daily Volume3 Month |
9,036 |
| Average Volume |
9,036 |
| Average Volume10Days |
3,660 |
| Bid |
3.0 |
| Bid Size |
7 |
| Book Value |
1.121 |
| City |
Kloten |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Country |
Switzerland |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
2.84 |
| Current Ratio |
0.397 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,790,726,400 |
| Day High |
3.2787 |
| Day Low |
2.81 |
| Debt To Equity |
6.489 |
| Display Name |
NewcelX |
| Dividend Yield |
0.0 |
| Ebitda |
-3,979,000 |
| Ebitda Margins |
0.0 |
| Enterprise To Ebitda |
-3.764 |
| Enterprise Value |
14,975,194 |
| Eps Current Year |
-1.18 |
| Eps Forward |
-0.6 |
| Eps Trailing Twelve Months |
0.52 |
| Esg Populated |
0 |
| Exchange |
NCM |
| Exchange Data Delayed By |
15 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fax |
41 44 512 21 51 |
| Fifty Day Average |
3.21842 |
| Fifty Day Average Change |
-0.3784201 |
| Fifty Day Average Change Percent |
-0.11757947 |
| Fifty Two Week Change Percent |
-82.91765 |
| Fifty Two Week High |
18.1 |
| Fifty Two Week High Change |
-15.26 |
| Fifty Two Week High Change Percent |
-0.84309393 |
| Fifty Two Week Low |
1.83 |
| Fifty Two Week Low Change |
1.0099999 |
| Fifty Two Week Low Change Percent |
0.5519125 |
| Fifty Two Week Range |
1.83 - 18.1 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,611,930,600,000 |
| Float Shares |
2,501,562 |
| Forward Eps |
-0.6 |
| Forward P E |
-4.733333 |
| Free Cashflow |
-12,319,058 |
| Full Exchange Name |
NasdaqCM |
| Full Time Employees |
9 |
| Fullday Change |
-0.063899994 |
| Fullday Change Percent |
-2.2004888 |
| Fullday Price |
2.84 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Gross Margins |
0.0 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.65575 |
| Held Percent Institutions |
0.00226 |
| Implied Shares Outstanding |
5,776,128 |
| Industry |
Biotechnology |
| Industry Disp |
Biotechnology |
| Industry Key |
biotechnology |
| Language |
en-US |
| Last Fiscal Year End |
1,767,139,200 |
| Last Split Date |
1,761,868,800 |
| Last Split Factor |
1:10 |
| Long Business Summary |
NewcelX Ltd., a biopharmaceutical company, engages in developing transformative stem-cell-derived therapies for Diabetes. The company develops NCEL-101, a cellular therapy product based on enriched pancreatic islet-like clusters for the treatment of Type 1 diabetes and Type 2 insulin dependent diabetes; AstroRx, an off-the-shelf cryopreserved cell therapy product for the treatment of Amyotrophic Lateral Sclerosis and neurodegenerative indications; and Dual Orexin-Receptor Agonist (DOXA), a small molecules platform for the treatment of sleep disorders, Neurodegenerative/ neuroinflammation diseases, and Diabetes Associated Neurological Disorders. It also develops iTOL-102, NCEL-201, NCEL-301, and NCEL-007. NewcelX Ltd. was founded in 2008 and is headquartered in Kloten, Switzerland. |
| Long Name |
NewcelX Ltd. |
| Market |
us_market |
| Market Cap |
16,404,203 |
| Market State |
PREPRE |
| Max Age |
86,400 |
| Message Board Id |
finmb_224505747 |
| Most Recent Quarter |
1,782,777,600 |
| Name Change Date |
2,026-10-14 |
| Net Income To Common |
-2,670,000 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
16,519,726 |
| Number Of Analyst Opinions |
1 |
| Open |
2.83 |
| Operating Cashflow |
-5,036,000 |
| Operating Margins |
0.0 |
| Payout Ratio |
0.0 |
| Phone |
41 44 512 21 50 |
| Prev Name |
Kadimastem Ltd |
| Previous Close |
2.9039 |
| Price Eps Current Year |
-2.4067798 |
| Price Hint |
4 |
| Price To Book |
2.533452 |
| Profit Margins |
0.0 |
| Quick Ratio |
0.208 |
| Quote Source Name |
Delayed Quote |
| Quote Type |
EQUITY |
| Recommendation Key |
none |
| Region |
US |
| Regular Market Change |
-0.063899994 |
| Regular Market Change Percent |
-2.200489 |
| Regular Market Day High |
3.2787 |
| Regular Market Day Low |
2.81 |
| Regular Market Day Range |
2.81 - 3.2787 |
| Regular Market Open |
2.83 |
| Regular Market Previous Close |
2.9039 |
| Regular Market Price |
2.84 |
| Regular Market Time |
1,791,921,600 |
| Regular Market Volume |
5,393 |
| Return On Assets |
-0.49588 |
| Sand P52 Week Change |
0.17502642 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Shares Outstanding |
5,776,128 |
| Shares Percent Shares Out |
0.0017 |
| Shares Short |
9,777 |
| Shares Short Previous Month Date |
1,788,134,400 |
| Shares Short Prior Month |
19,676 |
| Short Name |
NewcelX Ltd. |
| Short Ratio |
1.73 |
| Source Interval |
15 |
| Symbol |
NCEL |
| Target High Price |
23.0 |
| Target Low Price |
23.0 |
| Target Mean Price |
23.0 |
| Target Median Price |
23.0 |
| Total Cash |
710,000 |
| Total Cash Per Share |
0.132 |
| Total Debt |
392,000 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
0.52 |
| Trailing P E |
5.4615383 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
3.07494 |
| Two Hundred Day Average Change |
-0.23494005 |
| Two Hundred Day Average Change Percent |
-0.07640476 |
| Type Disp |
Equity |
| Volume |
5,393 |
| Website |
https://newcelx.com |
| Zip |
8,302 |